Telix Pharmaceuticals 2024 J.P. Morgan Healthcare Conference

Telix Pharmaceuticals presented its theranostic radiopharma pipeline at the J.P. Morgan Healthcare Conference in January 2024, highlighting commercial success of its imaging product Illuccix® and late-stage development programs in oncology. The company showcased TLX250-CDx for kidney cancer imaging and pipeline assets utilizing alpha and beta emitters, supported by strong revenue growth and vertically integrated manufacturing capabilities.